Related Experiment Video
Updated: Jun 22, 2026

10:14
Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Age-related macular degeneration.
1Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania 19104, USA. brucker@retinajournal.com
Retina (Philadelphia, Pa.)
|June 26, 2009
Summary
Age-related macular degeneration (AMD) causes vision loss in older adults. Current treatments slow AMD progression, but new therapies are needed to address multiple disease processes for better control.
Area of Science:
- Ophthalmology
- Gerontology
- Pathophysiology
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision impairment in the elderly.
- Wet AMD involves choroidal neovascularization, leading to macular damage and vision loss.
- Current anti-angiogenesis treatments for AMD slow disease progression but do not offer a cure.
Purpose of the Study:
- To highlight the limitations of current AMD treatments.
- To emphasize the need for a deeper understanding of AMD pathophysiology.
- To advocate for the development of novel therapies targeting multiple disease pathways.
Main Methods:
- Review of current literature on AMD pathophysiology and treatment.
- Analysis of the mechanisms underlying choroidal neovascularization.
- Discussion of the limitations of existing anti-angiogenesis therapies.
Main Results:
- Anti-angiogenesis agents are effective in halting or slowing AMD progression.
- These treatments do not provide a cure for AMD.
- Simultaneous targeting of multiple pathophysiologic processes is likely necessary for improved disease control.
Conclusions:
- Further research into the complex pathophysiology of AMD is crucial.
- Developing treatments that address multiple disease mechanisms is essential for effective AMD management.
- A comprehensive understanding of AMD will drive the innovation of more effective therapeutic strategies.
More Related Videos
Related Concept Videos
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Photoreceptors and Visual Pathways
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

